Want to see HK:9886 full AI Analyst Report?
9886 Stock Chart & Stats
HK$0.88
HK$0.00(0.00%)
At close: 4:00 PM EDT
HK$0.88
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$0.66 - HK$1.37
Previous CloseN/A
Volume21.50K
Average Volume (3M)391.33K
Market Cap
HK$963.97M
Enterprise ValueHK$199.57
Total Cash (Recent Filing)HK$1.13B
Total Debt (Recent Filing)HK$261.79M
Price to Earnings (P/E)―
Beta1.52
Next Earnings
Mar 31, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding1,240,312,900
10 Day Avg. Volume174,150
30 Day Avg. Volume391,333
Financial Highlights & Ratios
PEG Ratio0.29
Price to Book (P/B)0.75
Price to Sales (P/S)0.26
P/FCF Ratio10.18
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-1.35
Revenue Forecast (FY)HK$126.42B
Bulls Say, Bears Say
Bulls Say
Strong Revenue ReaccelerationThe sharp TTM revenue acceleration indicates stronger demand and improving commercial traction across the company’s digital pharmacy and healthcare platform. If sustained, this growth can expand the operating base, improve fixed-cost absorption, and support continued investment in fulfillment and online services.
Low Financial LeverageConservative leverage gives Dingdang Health greater financial flexibility while it continues moving toward profitability. Limited debt relative to equity reduces balance-sheet pressure, preserves capacity to fund operations internally, and lowers the risk that interest obligations constrain investment in its pharmacy and digital network.
Positive Operating And Free Cash FlowPositive operating and free cash flow show that the business has improved its ability to convert operations into cash, an important foundation for durable growth. This supports funding for pharmacy fulfillment capabilities and healthcare services without relying entirely on external capital.
Bears Say
Earnings Remain NegativeAlthough losses have narrowed substantially, the company has not yet established positive earnings or a durable profit buffer. Continued negative earnings leave less capacity to absorb pricing, cost, or execution pressure, and make successful operating leverage essential for strengthening long-term financial resilience.
Negative Returns On EquityNegative returns on equity indicate that the company is still not generating an adequate return from its capital base. The decline in equity versus 2023 further highlights the cumulative impact of losses, making sustained profitability necessary to rebuild capital organically and improve shareholder economics.
Softening Cash ConversionThe reversal in free cash flow growth suggests that recent cash conversion has weakened despite cash flow remaining positive in absolute terms. Modest operating cash flow relative to debt also indicates that debt coverage is improving but not yet especially strong, limiting the comfort provided by current liquidity generation.
Dingdang Health Technology Group Ltd. News
9886 FAQ
What was Dingdang Health Technology Group Ltd.’s price range in the past 12 months?
Dingdang Health Technology Group Ltd. lowest stock price was HK$0.66 and its highest was HK$1.37 in the past 12 months.
What is Dingdang Health Technology Group Ltd.’s market cap?
Dingdang Health Technology Group Ltd.’s market cap is HK$963.97M.
When is Dingdang Health Technology Group Ltd.’s upcoming earnings report date?
Dingdang Health Technology Group Ltd.’s upcoming earnings report date is Mar 31, 2027 which is in 181 days.
How were Dingdang Health Technology Group Ltd.’s earnings last quarter?
Dingdang Health Technology Group Ltd. released its earnings results on Aug 21, 2026. The company reported -HK$0.058 earnings per share for the quarter.
Is Dingdang Health Technology Group Ltd. overvalued?
According to Wall Street analysts Dingdang Health Technology Group Ltd.’s price is currently Overvalued.
Does Dingdang Health Technology Group Ltd. pay dividends?
Dingdang Health Technology Group Ltd. does not currently pay dividends.
What is Dingdang Health Technology Group Ltd.’s EPS estimate?
Dingdang Health Technology Group Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Dingdang Health Technology Group Ltd. have?
Dingdang Health Technology Group Ltd. has 1,240,312,900 shares outstanding.
What happened to Dingdang Health Technology Group Ltd.’s price movement after its last earnings report?
Dingdang Health Technology Group Ltd. reported an EPS of -HK$0.058 in its last earnings report. Following the earnings report the stock price went down -2.5%.
Which hedge fund is a major shareholder of Dingdang Health Technology Group Ltd.?
Currently, no hedge funds are holding shares in HK:9886
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Dingdang Health Technology Group Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-3.65%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
3.62%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Dingdang Health Technology Group Ltd.
Dingdang Health Technology Group Ltd. is a digital retail pharmacy firm operating within the People's Republic of China. The company provides online sales of pharmaceutical products alongside medical consultation services. Founded in 2014, it is based in Beijing, China.
Technical Analysis
Innovative Pharmaceutical Biotech
―
Natural Beauty Bio-Technology
―
Cheerwin Group Limited
―
EC Healthcare
―
Giant Biogene Holding Co. Ltd.
―